Interference of the cyanide antidote hydroxocobalamin with carboxyhemoglobin measurements should not limit clinical use in suspected or confirmed cyanide poisoning

被引：5
|
作者：
Borron, Stephen W. [1 ]
Uhl, Wolfgang
Nolting, Arno
Hostalek, Ulrike
Serono, Merck
机构：
[1] Univ Texas, Hlth Sci Ctr, San Antonio, TX 78229 USA
[2] Merck Serono, Darmstadt, Germany
来源：
ANNALS OF EMERGENCY MEDICINE | 2007年 / 50卷 / 05期
关键词：
D O I：
10.1016/j.annemergmed.2007.05.027
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：624 / 625
页数：2
相关论文
共 17 条
  • [1] Safety of hydroxocobalamin use in the Prehospital setting as an antidote for smoke inhalation associated cyanide poisoning
    Baud, F.
    Borron, S.
    ANNALS OF EMERGENCY MEDICINE, 2006, 48 (04) : S55 - S55
  • [2] Patterns of Cyanide Antidote Use Since Regulatory Approval of Hydroxocobalamin in the United States
    Streitz, Matthew J.
    Bebarta, Vikhyat S.
    Borys, Douglas J.
    Morgan, David L.
    AMERICAN JOURNAL OF THERAPEUTICS, 2014, 21 (04) : 244 - 249
  • [3] ECONOMIC EVALUATION OF THE IMPACT RESULTS OF HYDROXOCOBALAMIN USE IN VICTIMS OF SUSPECTED CYANIDE POISONING CAUSED BY SMOKE INHALATION
    Bikourane, N.
    Texier, N.
    Pouriel, M.
    Wittwer, J.
    VALUE IN HEALTH, 2022, 25 (01) : S84 - S85
  • [4] Belgian cost-effectiveness analysis of hydroxocobalamin (Cyanokit) in known or suspected cyanide poisoning
    Drieskens, Severien
    Anseeuw, Kurt
    Annemans, Lieven
    Fetro, Christine
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY-SCIENCE AND PRACTICE, 2013, 20 (03): : 161 - 167
  • [5] Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients
    Matthieu Legrand
    Thibault Michel
    Michel Daudon
    Mourad Benyamina
    Axelle Ferry
    Sabri Soussi
    Véronique Maurel
    Maïte Chaussard
    Marc Chaouat
    Maurice Mimoun
    Jérôme Verine
    Vincent Mallet
    Alexandre Mebazaa
    Intensive Care Medicine, 2016, 42 : 1080 - 1081
  • [6] Risk of oxalate nephropathy with the use of cyanide antidote hydroxocobalamin in critically ill burn patients
    Legrand, Matthieu
    Michel, Thibault
    Daudon, Michel
    Benyamina, Mourad
    Ferry, Axelle
    Soussi, Sabri
    Maurel, Veronique
    Chaussard, Maite
    Chaouat, Marc
    Mimoun, Maurice
    Verine, Jerome
    Mallet, Vincent
    Mebazaa, Alexandre
    INTENSIVE CARE MEDICINE, 2016, 42 (06) : 1080 - 1081
  • [7] Antidote treatment for cyanide poisoning with hydroxocobalamin causes bright pink discolouration and chemical-analytical interferences
    Brunel, C.
    Widmer, C.
    Augsburger, M.
    Dussy, F.
    Fracasso, T.
    FORENSIC SCIENCE INTERNATIONAL, 2012, 223 (1-3) : E10 - E12
  • [8] Evaluation of hydroxocobalamin use for the treatment of suspected cyanide toxicity secondary to smoke inhalation
    Kamta, Jeff
    Maynard, Kaylee
    Schult, Rachel F.
    Bell, Derek E.
    Jones, Courtney M. C.
    Acquisto, Nicole M.
    BURNS, 2024, 50 (01) : 157 - 166
  • [9] Liquid chromatographic mass spectrometric (LC/MS/MS) determination of plasma hydroxocobalamin and cyanocobalamin concentrations after hydroxocobalamin antidote treatment for cyanide poisoning
    Schwertner, Harvey A.
    Valtier, Sandra
    Bebarta, Vikhyat S.
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 905 : 10 - 16
  • [10] Potential interference by hydroxocobalamin on cooximetry hemoglobin measurements during cyanide and smoke inhalation treatments
    Lee, Jangwoen
    Mukai, David
    Kreuter, Kelly
    Mahon, Sari
    Tromberg, Bruce
    Brenner, Matthew
    ANNALS OF EMERGENCY MEDICINE, 2007, 49 (06) : 802 - 805
12